TY - JOUR
T1 - Treatment of non-small-cell lung cancer with erlotinib or gefitinib
AU - Cataldo, Vince D.
AU - Gibbons, Don L.
AU - Pérez-Soler, Román
AU - Quintás-Cardama, Alfonso
PY - 2011/3/10
Y1 - 2011/3/10
N2 - A 64-year-old woman who has never smoked receives the diagnosis of stage I adenocarcinoma of the lung and undergoes right upper lobectomy. One year later, bone and liver metastases develop. She is treated with carboplatin, paclitaxel, and bevacizumab, but progressive bone metastases are noted after 6 weeks of therapy. An oncologist recommends the initiation of erlotinib therapy.
AB - A 64-year-old woman who has never smoked receives the diagnosis of stage I adenocarcinoma of the lung and undergoes right upper lobectomy. One year later, bone and liver metastases develop. She is treated with carboplatin, paclitaxel, and bevacizumab, but progressive bone metastases are noted after 6 weeks of therapy. An oncologist recommends the initiation of erlotinib therapy.
UR - http://www.scopus.com/inward/record.url?scp=79952376771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952376771&partnerID=8YFLogxK
U2 - 10.1056/NEJMct0807960
DO - 10.1056/NEJMct0807960
M3 - Article
C2 - 21388312
AN - SCOPUS:79952376771
SN - 0028-4793
VL - 364
SP - 947
EP - 955
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 10
ER -
